ARCHIVES

Opioid Pain Reliever Approved With Risk Reduction Plan

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997